29/12/2010

The head of the Biomedical Research and Translational and Pediatric Oncology Unit at Vall d'Hebron, Institut de Recerca (VHIR), Dr. Jaume Reventós, participated in a session aimed at prostate cancer patients and their families, where he explained the latest developments in the investigation of his group. The seminar, organized by the Board of Barcelona of the Spanish Association Against Cancer at Hospital Duran Reynals from l'Hospitalet de Llobregat, was aimed at men who suffer from this disease, and was intended to highlight the prevention and provide on the latest treatments.During the talk, Dr. Reventós stressed that "with the advent of molecular biology, in particular, techniques of genomics and proteomics, we are able to detect other markers that can lead us towards the existence of a cancer”. The event also counted with Dr. Joan Palou, Head of Urologic Oncology at Puigvert Foundation and with Dr. Ferran Guedea, head of radiotherapy department of the ICO.